Subscribe to the CrunchBase Daily
for the latest on Fundings, Acquisitions, and Startup Events
Atheneos Capital’s goal is to enable rapid ROI in life science focused investments to all stakeholders in such investments. This will be achieved by combining entrepreneur managed funding of high quality early stage projects to build and sell ultra microcap companies (investorpreneurship) that employ cost effective product development (distributed development) with risk managed investments.
|Altheos ||4/2010||Series A||$20M||5|
Glaucoma drug focus inspires $20M A round for Altheos (fiercebiotech.com)